UNSPSC 85385301: Diagnosis of late metabolic acidosis of newborn

This classification denotes the group of activities that yields a diagnosis of Late metabolic acidosis of newborn. Late metabolic acidosis of newborn is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code P74. 0

UNSPSC 85385301 Diagnosis of late metabolic acidosis of newborn is a Commodity code, but the recent state and local contract opportunities posted under it do not match the code's nominal diagnostic scope. The three most recent opportunities — a diagnostic imaging Picture Archiving and Communication System (PACS) implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District in Texas, and temporary health professional staffing services across the County of Santa Clara Health System — span healthcare IT infrastructure, school-based ancillary services, and temporary clinical staffing. None directly address neonatal metabolic acidosis diagnosis. The code shows little relevant recent activity aligned to its stated clinical domain.

The geographic spread across California and Texas reflects only the jurisdictions supporting the three posted opportunities, with no additional concentration visible. San Mateo Medical Center is soliciting an enterprise PACS implementation due October 21, 2026 with a 5–10% local preference under County Ordinance; the County of Santa Clara Health System is building a qualified vendor pool for temporary health professional staffing across 13 ancillary clinical categories (posted July 7, 2026, due October 7, 2026) on a non-exclusive, multiple-award basis with no guaranteed work. Because the recent opportunities do not substantiate procurement activity in the neonatal diagnostic space this code describes, a business development strategy should verify whether the code is actively used by state and local buyers for the actual products or services the firm supplies, or whether mistagging in the source data obscures the genuine market opportunity.